Journal of Pediatric Hematology/Oncology 2006-Oct
Antitumor activity of nifurtimox observed in a patient with neuroblastoma.
Straipsnius versti gali tik registruoti vartotojai
Prisijungti Registracija
Nuoroda įrašoma į mainų sritį
Raktažodžiai
Santrauka
BACKGROUND
Chemotherapy-resistant neuroblastoma is a difficult disease to treat with poor survival.
METHODS
We treated a patient with neuroblastoma who had progressed on conventional chemotherapy. This 5-year-old girl with chemotherapy-resistant neuroblastoma developed Chagas disease at the start of salvage chemotherapy for which she was also started on nifurtimox. The neuroblastoma response to these treatments resulted in clinical remission. In vitro, treatment of a neuroblastoma cell line with nifurtimox resulted in decreased cell viability whereas no effect was seen on an endothelial cell line.
CONCLUSIONS
Nifurtimox shows promise as a potential new treatment for neuroblastoma and warrants further testing.
